On November 30, 2011 Ranbaxy Laboratories launched the generic equivalent for Lipitor, atorvastatin. Â Ranbaxy will be the sole manufacturer of this generic drug for the next 180 days. Â Other manufacturers of the drug will be available in May 2012.
The savings at the beginning will be minimal, but once May 2012 roles around we should see substantial savings. Â This means big savings to consumers and payers alike.